cases in detail

Challenge:

This client developed two kinds of HPV vaccines in pre-clinical/phase 1 stage and planned to proceed with clinical trails and launch in both US and China markets. However, the client is clear of its market potential which is essential when negotiating with potential partners/investors.

Solution:

•To build and enhance the commercial value story for HPV vaccine based on existing/previous and new research 

•To conduct a survey with HPV vaccine non-confidential information (blinded) with key stakeholders 

•To create a credible valuation model which communicates the NPV of the asset across different clinical and commercial scenarios 

•To initiate and strategically advance negotiations; orchestrate transaction process including term sheet analysis and management of communication streams

Achievement:

•Obtained key stakeholders' feedback on pricing, reimbursement and market potential 

•Defined Different scenario of estimated NPV with robust methodology 

•Key product value story and leverage points enabled client to successfully establish discussion with the partners